Clinical trial

Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance…

NCT00003825 · Radiation Therapy Oncology Group, Other · Completed

Key facts

NCT number NCT00003825
Title Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Official title Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Diarrhea, Radiation Enteritis
Intervention type Drug, Procedure
Interventions pentosan polysulfate sodium, quality-of-life assessment
Enrollment 174
Start date Jun 1, 1999
Primary completion Apr 1, 2006
First posted May 3, 2004
Last update posted Oct 19, 2020
Countries Canada, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies